Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://heathrjwq230548.nizarblog.com/39306873/retaglutide-a-promising-glp-1-receptor-agonist